Dynamics of Anti-influenza Mucosal IgA Over a Season in a Cohort of Individuals Living or Working in a Long-term Care Facility
Open Access
- 6 February 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 228 (4) , 383-390
Abstract
Background: Serological surveys are used to ascertain influenza infection and immunity, but evidence for the utility of mucosal immunoglobulin A (IgA) as a correlate of infection or protection is limited. Methods: We performed influenza-like illness (ILI) surveillance on 220 individuals living or working in a retirement community in Gainesville, Florida from January to May 2018, and took pre- and postseason nasal samples of 11 individuals with polymerase chain reaction (PCR)-confirmed influenza infection and 60 randomly selected controls. Mucosal IgA against 10 strains of influenza was measured from nasal samples. Results: Overall, 28.2% and 11.3% of individuals experienced a 2-fold and 4-fold rise, respectively, in mucosal IgA to at least 1 influenza strain. Individuals with PCR-confirmed influenza A had significantly lower levels of preseason IgA to influenza A. Influenza-associated respiratory illness was associated with a higher rise in mucosal IgA to influenza strains of the same subtype, and H3N2-associated respiratory illness was associated with a higher rise in mucosal IgA to other influenza A strains. Conclusions: By comparing individuals with and without influenza illness, we demonstrated that mucosal IgA is a correlate of influenza infection. There was evidence for cross-reactivity in mucosal IgA across influenza A subtypes.Keywords
Funding Information
- University of Florida
This publication has 39 references indexed in Scilit:
- Influenza Infection Rates, Measurement Errors and the Interpretation of Paired SerologyPLOS Pathogens, 2012
- Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in AdultsThe Journal of Infectious Diseases, 2012
- Mucosal IgA responses in influenza virus infections; thoughts for vaccine designVaccine, 2012
- Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine FailuresThe Journal of Infectious Diseases, 2011
- Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational StudyPLOS ONE, 2010
- Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adultsVaccine, 2009
- A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adultsVaccine, 2009
- Secretory IgA antibodies provide cross‐protection against infection with different strains of influenza B virusJournal of Medical Virology, 2004
- The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus1970
- Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine1969